Table 2 Cell lines from ovarian endometrioid adenocarcinoma

#2774 (1978)

-

ascites

66-68

-

Yes

-

-

- (1983)

47

ascites

103 (51–402)

74.4

Yes

-

-

OVK18 (1983)

49

ascites

47 (mode)

48

Yes

-

ER(−), PgR(−)

HMOA (1986)

57

ovarian tumor

46-47 (mode)

72, 58

Yes

-

production of CA125

HNOA (1986)

71

transplanted tumor

46-47 (mode)

28, 24

Yes

-

CA125(−)

HOC-I (1989)

40

recurrent tumor

46 (44–49)

75

Yes

ER(−)

ER(−), production of CA125, TPA

COV362 (1993)

-

-

69 (67–73)

-

-

-

-

SIB-1 (1994)

39

pleural effusion

46 (43–54)

-

-

HMFG-2, CA125

serum free medium

SNU-251 (1997)

47

ascites

-

46

-

-

CA125(−), CEA(−), p53, BRCA1, hMLH1 mutation(+)

SNU-563 (1997)

54

ovarian tumor

-

67

-

-

p53 mutation(+)

NOE (2007)

46

tumor fluid

65-74

-

Yes

-

ER(+)

NOMH-1

44

ovarian tumor

73-80

273

Yes

CA19-9, CEA, ER(−), PgR(−)

production of CA19-9, CEA, TPA